Evidence method
Level · gp.fundamentals.debt_to_revenue
191.63% · OPTIONAL · NOT_ENOUGH_HISTORY
Profound Medical Corp.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
Level · gp.fundamentals.debt_to_revenue
191.63% · OPTIONAL · NOT_ENOUGH_HISTORY
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-353.82% · OPTIONAL · NOT_ENOUGH_HISTORY
Level · gp.fundamentals.inventory_revenue_ratio
290.26% · OPTIONAL · NOT_ENOUGH_HISTORY
Level · gp.fundamentals.gross_margin
79.15% · CORE · NOT_ENOUGH_HISTORY
Level · gp.fundamentals.operating_margin
-476.98% · CORE · NOT_ENOUGH_HISTORY
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
205.38% · OPTIONAL · NOT_ENOUGH_HISTORY
Level · gp.fundamentals.sbc_revenue_ratio
42.25% · OPTIONAL · NOT_ENOUGH_HISTORY
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.